DR. JAMES FRANCIS ROONEY, M.D.
Osteopathic Medicine at Lakeside Dr, San Mateo, CA
License number
California A70171
Category
Osteopathic Medicine
Type
Infectious Disease
License number
California 22828
Category
Osteopathic Medicine
Type
Infectious Disease
License number
California 15386
Category
Osteopathic Medicine
Type
Infectious Disease
Address
Address
2
333 Lakeside Dr, San Mateo, CA 94404
118 Westridge Dr, Menlo Park, CA 94028
118 Westridge Dr, Menlo Park, CA 94028
Phone
(650) 522-5708
(650) 522-5854 (Fax)
(650) 233-0352
(650) 522-5854 (Fax)
(650) 233-0352
Professional information
Dr. James F Rooney, San Mateo CA - MD (Doctor of Medicine)
Specialties:
Infectious Disease Medicine
Address:
GILEAD SCIENCES
335 Lakeside Dr, San Mateo 94404
(650) 522-5708 (Phone), (650) 522-5854 (Fax)
335 Lakeside Dr, San Mateo 94404
(650) 522-5708 (Phone), (650) 522-5854 (Fax)
Certifications:
Infectious Disease, 1986, Internal Medicine, 1981
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Maryland At Baltimore / Professional Schools
Graduated: 1978
University Of Maryland Medical Center
Natl Inst Hlth
University of Maryland At Baltimore / Professional Schools
Graduated: 1978
University Of Maryland Medical Center
Natl Inst Hlth
Topical Antiviral Formulations For Prevention Of Transmission Of Hsv-2
US Patent:
2013021, Aug 22, 2013
Filed:
Jun 7, 2011
Appl. No.:
13/700710
Inventors:
Quarraisha Abdool Karim - Durban, ZA
Salim S. Abdool Karim - Durban, ZA
Ayesha Kharsany - Durban, ZA
Tomas Cihlar - Foster City CA, US
James F. Rooney - Foster City CA, US
Salim S. Abdool Karim - Durban, ZA
Ayesha Kharsany - Durban, ZA
Tomas Cihlar - Foster City CA, US
James F. Rooney - Foster City CA, US
International Classification:
A61K 31/675, A61K 9/00
US Classification:
424400, 514 81
Abstract:
The present invention relates to formulations of antiviral compounds, in particular [2-(6-amino-purin-9-yl)-1-methyl-ethoxymethyl]-phosphonic acid (tenofovir, PMPA), suitable for topical application, and to their use in the reduction of or prevention of acquisition and transmission of herpes simplex virus.